11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients : Results of the INSIGHT case-control study
- Contribution to journal › Article
-
Mark
Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
(2017) In Proceedings of the National Academy of Sciences of the United States of America 114(25). p.6444-6449
- Contribution to journal › Article
-
Mark
Plasma-derived versus recombinant factor concentrates in PUPs : A never ending debate?
- Contribution to journal › Article
- 2016
-
Mark
Inhibitor development in previously untreated patients with severe haemophilia A : a nationwide multicentre study in Finland
- Contribution to journal › Article
-
Mark
Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro
- Contribution to journal › Article
-
Mark
Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact : A case report
- Contribution to journal › Article
-
Mark
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod : Blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth
- Contribution to journal › Article
-
Mark
Haemophilia treatment in 2030
- Contribution to journal › Article
- 2014
-
Mark
Managing Haemophilia for Life: 4th Haemophilia Global Summit
- Contribution to journal › Scientific review
- 2013
-
Mark
Health-Related Quality of Life and Adherence in Haemophilia
- Thesis › Doctoral thesis (compilation)
